Publication Information

{'id': 'https://openalex.org/W2366583741', 'doi': None, 'title': 'The relationship between dose of risperidone and the steady plasma concentrations of risperidone and 9-hydroxyrisperidone in schizophrenic patients', 'display_name': 'The relationship between dose of risperidone and the steady plasma concentrations of risperidone and 9-hydroxyrisperidone in schizophrenic patients', 'publication_year': 2005, 'publication_date': '2005-01-01', 'ids': {'openalex': 'https://openalex.org/W2366583741', 'mag': '2366583741'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'http://en.cnki.com.cn/Article_en/CJFDTOTAL-ZGYZ200507009.htm', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764621253', 'display_name': 'Chinese Journal of Hospital Pharmacy', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/P4323237960', 'host_organization_name': 'Chinese Journal of Hospital Pharmacy editorial department', 'host_organization_lineage': ['https://openalex.org/P4323237960'], 'host_organization_lineage_names': ['Chinese Journal of Hospital Pharmacy editorial department'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': [], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5056161976', 'display_name': 'Wei Chuan-mei', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': True, 'raw_author_name': 'Wei Chuan-mei', 'raw_affiliation_strings': ['~1,FU Chong-ming~2,GUO Rui-chen~3'], 'affiliations': [{'raw_affiliation_string': '~1,FU Chong-ming~2,GUO Rui-chen~3', 'institution_ids': []}]}], 'institution_assertions': [], 'countries_distinct_count': 0, 'institutions_distinct_count': 0, 'corresponding_author_ids': ['https://openalex.org/A5056161976'], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 1, 'citation_normalized_percentile': {'value': 0.417365, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 61, 'max': 68}, 'biblio': {'volume': None, 'issue': None, 'first_page': None, 'last_page': None}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10023', 'display_name': 'Schizophrenia research and treatment', 'score': 0.9849, 'subfield': {'id': 'https://openalex.org/subfields/2738', 'display_name': 'Psychiatry and Mental health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10023', 'display_name': 'Schizophrenia research and treatment', 'score': 0.9849, 'subfield': {'id': 'https://openalex.org/subfields/2738', 'display_name': 'Psychiatry and Mental health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/dopamine-antagonist', 'display_name': 'Dopamine antagonist', 'score': 0.45544744}, {'id': 'https://openalex.org/keywords/paliperidone-palmitate', 'display_name': 'Paliperidone Palmitate', 'score': 0.44871172}], 'concepts': [{'id': 'https://openalex.org/C2780057945', 'wikidata': 'https://www.wikidata.org/wiki/Q412443', 'display_name': 'Risperidone', 'level': 3, 'score': 0.9782606}, {'id': 'https://openalex.org/C3020079912', 'wikidata': 'https://www.wikidata.org/wiki/Q3918988', 'display_name': 'Plasma concentration', 'level': 2, 'score': 0.6402412}, {'id': 'https://openalex.org/C2781353949', 'wikidata': 'https://www.wikidata.org/wiki/Q3271533', 'display_name': 'Dopamine antagonist', 'level': 4, 'score': 0.45544744}, {'id': 'https://openalex.org/C2908997079', 'wikidata': 'https://www.wikidata.org/wiki/Q27157250', 'display_name': 'Paliperidone Palmitate', 'level': 4, 'score': 0.44871172}, {'id': 'https://openalex.org/C2776412080', 'wikidata': 'https://www.wikidata.org/wiki/Q7431605', 'display_name': 'Schizophrenia (object-oriented programming)', 'level': 2, 'score': 0.42351833}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.40524232}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.40248248}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.27215564}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.21610153}, {'id': 'https://openalex.org/C118552586', 'wikidata': 'https://www.wikidata.org/wiki/Q7867', 'display_name': 'Psychiatry', 'level': 1, 'score': 0.1580672}, {'id': 'https://openalex.org/C170493617', 'wikidata': 'https://www.wikidata.org/wiki/Q208467', 'display_name': 'Receptor', 'level': 2, 'score': 0.12731728}, {'id': 'https://openalex.org/C2776885963', 'wikidata': 'https://www.wikidata.org/wiki/Q245204', 'display_name': 'Antagonist', 'level': 3, 'score': 0.10663754}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'http://en.cnki.com.cn/Article_en/CJFDTOTAL-ZGYZ200507009.htm', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764621253', 'display_name': 'Chinese Journal of Hospital Pharmacy', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/P4323237960', 'host_organization_name': 'Chinese Journal of Hospital Pharmacy editorial department', 'host_organization_lineage': ['https://openalex.org/P4323237960'], 'host_organization_lineage_names': ['Chinese Journal of Hospital Pharmacy editorial department'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W3207213207', 'https://openalex.org/W2465684388', 'https://openalex.org/W2413334594', 'https://openalex.org/W2390395321', 'https://openalex.org/W2388825225', 'https://openalex.org/W2386304628', 'https://openalex.org/W2378616719', 'https://openalex.org/W2368325287', 'https://openalex.org/W2365171890', 'https://openalex.org/W2361037870', 'https://openalex.org/W2238900431', 'https://openalex.org/W2168445796', 'https://openalex.org/W2116935347', 'https://openalex.org/W2071330308', 'https://openalex.org/W2046598870', 'https://openalex.org/W2026993938', 'https://openalex.org/W1994627117', 'https://openalex.org/W1969738024', 'https://openalex.org/W155182020', 'https://openalex.org/W1439445912'], 'abstract_inverted_index': {'OBJECTIVE': [0], 'To': [1], 'evaluate': [2], 'the': [3, 10, 35, 75, 83, 105], 'relationship': [4, 36, 57, 67], 'between': [5, 37, 69], 'dose': [6, 71, 107], 'of': [7, 14, 25, 41, 53, 72, 95, 108, 112], 'risperidone': [8, 15, 26, 42, 73, 98, 109, 120], 'and': [9, 16, 27, 34, 43, 45, 74], 'steady': [11, 22, 50, 76, 92], 'plasma': [12, 23, 39, 51, 77, 93], 'concentration': [13, 40, 52, 78], '9-hydroxyrisperidone': [17, 28, 44, 79, 88, 96, 100, 114], 'in': [18, 119], 'schizophrenic': [19], 'patients.METHODS': [20], 'The': [21, 49, 91], 'concentrations': [24, 94], 'were': [29, 101], 'determined': [30], 'by': [31], 'HPLC-MS': [32], 'method': [33], 'total': [38, 84], 'doses': [46], 'are': [47], 'evaluated.RESULTS': [48], 'RSP': [54], 'had': [55], 'a': [56], 'with': [58], 'administered': [59], 'daily': [60], 'oral': [61], 'dose,r=0.766': [62], '8.': [63], 'A': [64], 'much': [65], 'better': [66], 'existed': [68], 'dialy': [70, 106], '(r=0.980': [80], '0)': [81], 'or': [82, 97], 'active': [85], 'moiety,risperidone': [86], 'plus': [87, 99], 'concentrations(r=0.979': [89], '8).CONCLUSION': [90], 'more': [102], 'related': [103], 'to': [104], 'than': [110], 'that': [111], 'risperidone.': [113], 'has': [115], 'an': [116], 'important': [117], 'role': [118], 'clinical': [121], 'application.': [122]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2366583741', 'counts_by_year': [{'year': 2019, 'cited_by_count': 1}], 'updated_date': '2024-12-10T17:07:33.763853', 'created_date': '2016-06-24'}